Protalix BioTherapeutics
PLX
#8411
Rank
S$0.23 B
Marketcap
$3.19
Share price
-1.65%
Change (1 day)
67.31%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -S$10.61 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$45.66 Million. In 2023 the company made an earning of S$15.7 Million, an increase over its 2022 earnings that were of -S$15.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$10.61 Million-167.53%
2023 S$15.7 M-199.05%
2022 -S$15.86 Million-40.38%
2021 -S$26.6 Million-732.31%
2020 S$4.2 M-130.53%
2019 -S$13.78 Million189.85%
2018 -S$4.76 Million-95.29%
2017 -S$0.11 Billion308.12%
2016 -S$24.73 Million-32.37%
2015 -S$36.57 Million10.11%
2014 -S$33.21 Million-7.59%
2013 -S$35.94 Million
2011 -S$41.62 Million-19.39%
2010 -S$51.63 Million20.87%
2009 -S$42.71 Million32.26%
2008 -S$32.3 Million-5.46%
2007 -S$34.16 Million
2004 -S$0.23 Million12.35%
2003 -S$0.2 Million-11.1%
2002 -S$0.23 Million-57.03%
2001 -S$0.52 Million1.03%
2000 -S$0.52 Million-53.22%
1999 -S$1.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$91.31 Million 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.68 B-6,716.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.27 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.38 Billion 3,534.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel